A study with more than 1000 patients finds that a new drug combo against recurring prostate cancer consisting of enzalutamide (Xtandi) and hormone therapy can reduce death risk by over 40 percent. See http://www.neat-news.com/3444.php. #prostate_cancer #death_risk #drug

A new meta-analysis finds that at any point in life it is not too late for an adult to change to a more active lifestyle in order to obtain the health benefits such as a 20 to 25 percent lower risk of death from any cause. See http://www.neat-news.com/3376.php. #active_lifestyle #death_risk